How is luspatercept typically administered to patients with lower-risk MDS?
At a fixed dose of 1.75 mg from the start of treatment
In a titrational mode, starting with 1 mg and escalating to 1.33 and then 1.75 mg
In combination with other medications to enhance its efficacy